Resume XIGDUO XR when the patient is clinically stable and has resumed oral intake [see Warnings and Precautions (5.2) and Clinical Pharmacology (12.2)]
Personalized obesity care is still several years away from widespread use
They will conduct a clinical assessment and recommend a personalized treatment regimen according to your health condition
A GLP-1 weight loss program review should answer more than one question: Will I lose weight? The better question is whether the program gives you safe prescribing, realistic expectations, consistent follow-up, and a plan you can continue after the first few months
Semaglutide, the molecule in Ozempic and Wegovy, is the compound in this class with actual human trial data on alcohol, and randomized trials have shown reduced heavy drinking and cravings in people with alcohol use disorder
This is especially common in patients using GLP-1 medications, which are prescribed to aid weight reduction